Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-127014
Filing Date
2024-11-14
Accepted
2024-11-14 16:01:35
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pstv-20240930.htm   iXBRL 10-Q 1773003
2 EX-3.10 pstv-ex3_10.htm EX-3.10 15791
3 EX-31.1 pstv-ex31_1.htm EX-31.1 13956
4 EX-31.2 pstv-ex31_2.htm EX-31.2 11255
5 EX-32.1 pstv-ex32_1.htm EX-32.1 13594
6 GRAPHIC img219049006_0.jpg GRAPHIC 8246
  Complete submission text file 0000950170-24-127014.txt   6726662

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pstv-20240930.xsd EX-101.SCH 1168753
61 EXTRACTED XBRL INSTANCE DOCUMENT pstv-20240930_htm.xml XML 736421
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34375 | Film No.: 241461555
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)